Edmond de Rothschild Holding’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Hold |
205,680
| – | – | 0.05% | 205 |
|
|
2025
Q1 | $2.8M | Hold |
205,680
| – | – | 0.05% | 200 |
|
|
2024
Q4 | $4.19M | Hold |
205,680
| – | – | 0.07% | 180 |
|
|
2024
Q3 | $5.99M | Hold |
205,680
| – | – | 0.1% | 154 |
|
|
2024
Q2 | $4.78M | Hold |
205,680
| – | – | 0.08% | 167 |
|
|
2024
Q1 | $4.22M | Buy |
205,680
+40,000
| +24% | +$821K | 0.07% | 171 |
|
|
2023
Q4 | $3.56M | Buy |
165,680
+65,800
| +66% | +$1.41M | 0.06% | 187 |
|
|
2023
Q3 | $2.06M | Hold |
99,880
| – | – | 0.04% | 236 |
|
|
2023
Q2 | $2.95M | Hold |
99,880
| – | – | 0.06% | 219 |
|
|
2023
Q1 | $2.3M | Hold |
99,880
| – | – | 0.05% | 235 |
|
|
2022
Q4 | $2.78M | Hold |
99,880
| – | – | 0.06% | 208 |
|
|
2022
Q3 | $3.07M | Hold |
99,880
| – | – | 0.08% | 198 |
|
|
2022
Q2 | $2.94M | Hold |
99,880
| – | – | 0.07% | 215 |
|
|
2022
Q1 | $3.21M | Hold |
99,880
| – | – | 0.07% | 201 |
|
|
2021
Q4 | $4.46M | Sell |
99,880
-120
| -0.1% | -$5.35K | 0.1% | 183 |
|
|
2021
Q3 | $5.05M | Buy |
100,000
+22,800
| +30% | +$1.15M | 0.12% | 163 |
|
|
2021
Q2 | $6.06M | Buy |
77,200
+20,200
| +35% | +$1.58M | 0.14% | 150 |
|
|
2021
Q1 | $3.26M | Buy |
57,000
+42,000
| +280% | +$2.4M | 0.09% | 196 |
|
|
2020
Q4 | $1.26M | Buy |
+15,000
| New | +$1.26M | 0.04% | 271 |
|